The debt biotechnology still owes Gregorio Marañón (and is now beginning to repay) 25/06/2026 Healthcare Access to innovation Personalized medicine In 1920, the Spanish physician and humanist Gregorio Marañón popularised and adopted the phrase coined by Hippocrates:... Partners - ProductLife Group
World ALS Day | “ALS research is currently going through a particularly promising moment” 21/06/2026 Healthcare Rare diseases Innovative drugs Personalized medicine We interview Alfonso de Egaña Barrenechea, CEO of Molefy Pharma, a company developing AP-2, an innovative molecule... AseBio - MOLEFY PHARMA
Research on the TDP-43 protein opens new therapeutic avenues for ALS 20/06/2026 Biotechnology is driving new strategies to combat ALS, including research on the TDP-43 protein, a key target involved... AseBio
BIOTECHX USA Boston United States Del 29/09/2026 to 30/09/2026 Healthcare Drug discovery Personalized medicine International
BCN HEALTH publishes a study evaluating the incidence and medical cost associated to intra... 03/06/2026 Healthcare Innovative drugs Personalized medicine Partners - BCN Health
The combination of biotechnology, biomarkers and clinical research is driving a new era in... 30/05/2026 SANOFI Biotechnology is redefining the approach to multiple sclerosis through new therapeutic tools, a more precise... AseBio - SANOFI
World Multiple Sclerosis Day | “Biotechnology is enabling progress toward a better underst... 29/05/2026 Healthcare Innovative drugs Personalized medicine On the occasion of World Multiple Sclerosis Day, we interviewed Sanofi, which has a research line specifically focused... AseBio - SANOFI
Opportunities in Healthy Aging 26/05/2026 Healthcare Personalized medicine Digitalization Rising life expectancy and increasing pressure on healthcare and social systems are driving a new market focused on... Partners - GENESIS Biomed
BCN HEALTH Will present two communications at the Jornadas AES to be held in June in Sevil... 27/05/2026 Healthcare Personalized medicine Advanced therapies BCN HEALTH will participate in the Jornadas AES, which will take place in Seville from June 17 to 19. Partners - BCN Health
VIVEbiotech Expands Lentiviral Vector Manufacturing Capabilities with EvoLVcell 18/05/2026 Healthcare Innovative drugs Personalized medicine Advanced therapies Transfection-free stable producer cell line (SCL) offers easy scalability, reduction of cost of goods (COGs), improve... Partners - VIVEbiotech
